Hybrid Design for Phase I Dose-Finding Studies
Overview
The Hybrid design is a combination of model-assisted design (e.g., the modified Toxicity Probability Interval design) with dose-toxicity model-based design for phase I dose-finding studies. The hybrid design controls the overdosing toxicity well and leads to a recommended dose closer to the true maximum tolerated dose (MTD) due to its ability to calibrate for an intermediate dose. More details can be found in Liao et al. 2022 doi:10.1002/ijc.34203.
Install
Health
- OK13 OK2026-08-05
- NOTE12 OK, 1 NOTE2026-08-01
- OK13 OK2026-05-10
- WARNING12 OK, 1 WARNING2026-05-09
- OK14 OK2026-03-10
Documentation
- Help pages
- 4
- Examples that run
- 75%3 run in a plain check · 1 only when donttest examples are enabled (R CMD check --as-cran)
- Exported functions with examples
- 100%
- Documented parameters
- 100%
- Return-value docs
- 100%
- Help pages citing references
- 0%
Downloads
Dependencies
Installing HybridDesign adds 3 packages (0 with compiled code, 451 KB of source tarballs). Heaviest: ResourceSelection 405 KB, pbapply 23 KB, testit 23 KB.
Code & Tests
People & History
- RR 4.6.0 released · 2026-04-24
- RR 4.5.0 released · 2025-04-11
- RR 4.4.0 released · 2024-04-24
- RR 4.3.0 released · 2023-04-21
- 1.0Latest2022-12-15 · current release
- RR 4.2.0 released · 2022-04-22
Package metadata
- First published
- 2022-12-15
- Total releases
- 1 / 4 yrs
- License
- GPL-3 OSI
- Minimum R
- ≥ 3.6
- Download size
- 7.6 KB
Cite
Cite this package
Run in R for the authors' preferred citation:
citation("HybridDesign")This package has no citation file, so citation() returns this entry built from DESCRIPTION.
Cite the R Observatory
For a number measured here: a download total, a coverage figure, an archival date.
From data release v2026-10-19, which the citation names so these numbers can be found later. More on citing and the projects behind them.